2004
DOI: 10.1002/ajh.20019
|View full text |Cite
|
Sign up to set email alerts
|

Cutaneous B‐cell lymphoma: Pathological spectrum and clinical outcome in 51 consecutive patients

Abstract: The clinical behavior and optimal treatment of patients presenting with skin infiltration by B-cell lymphoma have not been established. To clarify this we assessed the clinical and laboratory features of 51 patients presenting with cutaneous infiltration by B-cell lymphoma. Follow-up data was available for 46 patients with a median age of 68 years (range 16-89 years) and a median follow-up of 32.5 months (range 5-123 months). Thirty-three of 51 (65%) patients had diffuse large B-cell lymphoma (DLBCL), and 15/5… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
15
0

Year Published

2007
2007
2017
2017

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 21 publications
(16 citation statements)
references
References 39 publications
1
15
0
Order By: Relevance
“…Multiagent chemotherapy, mostly cyclophosphamide, doxorubicin (Adriamycin), oncovin (Vincristine), prednisone (CHOP), was administered to 33 PCMZL patients reported in the literature, again mostly patients with multifocal skin lesions. 21,25,30,40 CR rate was 85% and a relapse rate of 57% was found.…”
Section: Single-agent and Combination Chemotherapymentioning
confidence: 88%
See 3 more Smart Citations
“…Multiagent chemotherapy, mostly cyclophosphamide, doxorubicin (Adriamycin), oncovin (Vincristine), prednisone (CHOP), was administered to 33 PCMZL patients reported in the literature, again mostly patients with multifocal skin lesions. 21,25,30,40 CR rate was 85% and a relapse rate of 57% was found.…”
Section: Single-agent and Combination Chemotherapymentioning
confidence: 88%
“…There was a total number of 14 patients with a PCMZL in these studies, all with multifocal skin lesions. 23,25,31,39 The response rate was 100% with a CR in 9 patients (64%) and a partial remission in the other 5 patients. Of the 9 patients with a CR, 3 patients showed relapses (33%), one of whom also with extracutaneous localizations.…”
Section: Single-agent and Combination Chemotherapymentioning
confidence: 97%
See 2 more Smart Citations
“…PCFCCL demonstrated more localized disease with histological features showing a spectrum of centrocytes and centroblasts in diffuse or follicular patterns. [59] PCFCCL showed more favorable prognosis (five-year survival of 95%) than PCLBL-leg (five-year survival of 50%). GEP of PCLBCL demonstrated the distinction between these two subtypes of neoplasm at molecular levels.…”
Section: Primary Cutaneous Large B -Cell Lymphomasmentioning
confidence: 86%